Maternal obesity had a strong influence on offspring obesity/severe obesity, and maternal smoking had a significant effect on all 3 outcomes.

Pfizer has made the decision to discontinue the clinical development program for danuglipron, an oral GLP-1 receptor agonist, being investigated for chronic weight management.

There are substantial rural-urban disparities in cardiometabolic risk factors and cardiovascular diseases among US adults.